Skip to content
The Nexus
DossierENTITY

dengue vaccine

Coverage of dengue vaccine in the Nexus archive.

Earliest in view: Jun 9 · 07:43 UTCMost recent: Jun 15 · 09:45 UTC
Co-mentioned in this coverage
ICMRorganization1Indiaplace1third phase clinical trialstopic1Brazilplace1Butantan Instituteorganization1São Pauloplace1
Recent coverage
  • HEALTHJun 15 · 09:45 UTCTHE HINDU NATIONAL
    Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

    India's first dengue vaccine is nearing completion of its third phase clinical trials, according to ICMR. The country currently has no antiviral treatment or licensed vaccine for dengue and ranks among the top 30 nations with the highest incidence of the disease.

  • HEALTHJun 9 · 07:43 UTCMERCOPRESS
    Brazil suspends its dengue vaccine as a precaution after two deaths

    Brazil temporarily suspended its dengue vaccination campaign after detecting two deaths and serious adverse reactions. The single-dose vaccine, developed by the Butantan Institute in São Paulo, had been administered to half a million people. Health authorities stated there is insufficient data to link the deaths to the vaccine and emphasized the suspension is a preventive measure.